195 related articles for article (PubMed ID: 11558543)
1. Protective effects of clostridium sordellii LT and HT toxoids against challenge with spores in guinea pigs.
Amimoto K; Oishi E; Yasuhar H; Sasak O; Katayama S; Kitajima T; Izumida A; Hirahara T
J Vet Med Sci; 2001 Aug; 63(8):879-83. PubMed ID: 11558543
[TBL] [Abstract][Full Text] [Related]
2. Protective effect of Clostridium septicum alpha-toxoid vaccine against challenge with spores in guinea pigs.
Amimoto K; Ohgitani T; Sasaki O; Oishi E; Katayama S; Isogai M; Ota S
J Vet Med Sci; 2002 Jan; 64(1):67-9. PubMed ID: 11853149
[TBL] [Abstract][Full Text] [Related]
3. The protective effect of Clostridium novyi type B alpha-toxoid against challenge with spores in guinea pigs.
Amimoto K; Sasaki O; Isogai M; Kitajima T; Oishi E; Okada N; Yasuhara H
J Vet Med Sci; 1998 Jun; 60(6):681-5. PubMed ID: 9673937
[TBL] [Abstract][Full Text] [Related]
4. Genetic variation and cross-reactivity of Clostridium septicum alpha-toxin.
Amimoto K; Sasaki Y; Fukuyama S; Tamura Y
Vet Microbiol; 2006 Apr; 114(1-2):51-9. PubMed ID: 16337096
[TBL] [Abstract][Full Text] [Related]
5. Immunogenicity of Clostridium septicum in guinea pigs.
Claus KD; Kolbe DR
Am J Vet Res; 1979 Dec; 40(12):1752-6. PubMed ID: 525895
[TBL] [Abstract][Full Text] [Related]
6. [The study on the cloning and expression of alpha toxin gene of clostridium septicum and the immunity of the toxoid].
Zhang Y; Bian YQ; Zhao BH
Sheng Wu Gong Cheng Xue Bao; 2007 Jan; 23(1):67-72. PubMed ID: 17366890
[TBL] [Abstract][Full Text] [Related]
7. Use of allicin as feed additive to enhance vaccination capacity of Clostridium perfringens toxoid in rabbits.
Abu El Hammed W; Soufy H; El-Shemy A; Nasr SM; Dessouky MI
Vaccine; 2016 Apr; 34(17):2000-7. PubMed ID: 26973070
[TBL] [Abstract][Full Text] [Related]
8. Active and passive immunization to protect against antibiotic associated caecitis in hamsters.
Fernie DS; Thomson RO; Batty I; Walker PD
Dev Biol Stand; 1983; 53():325-32. PubMed ID: 6873474
[TBL] [Abstract][Full Text] [Related]
9. Clinicopathological and immunological studies on toxoids vaccine as a successful alternative in controlling clostridial infection in broilers.
Saleh N; Fathalla SI; Nabil R; Mosaad AA
Anaerobe; 2011 Dec; 17(6):426-30. PubMed ID: 21664285
[TBL] [Abstract][Full Text] [Related]
10. [A hemagglutination inhibition test for control of the quality and effectiveness of highly-purified C. chauvoei toxoid vaccine].
Roth F; Labarre B; Schmidt-Pannenbecker E
Berl Munch Tierarztl Wochenschr; 1989 Jan; 102(1):20-5. PubMed ID: 2923618
[TBL] [Abstract][Full Text] [Related]
11. Vaccination with parenteral toxoid B protects hamsters against lethal challenge with toxin A-negative, toxin B-positive clostridium difficile but does not prevent colonization.
Siddiqui F; O'Connor JR; Nagaro K; Cheknis A; Sambol SP; Vedantam G; Gerding DN; Johnson S
J Infect Dis; 2012 Jan; 205(1):128-33. PubMed ID: 22124129
[TBL] [Abstract][Full Text] [Related]
12. Potential protective immunogenicity of recombinant Clostridium perfringens α-β2-β1 fusion toxin in mice, sows and cows.
Zeng J; Deng G; Wang J; Zhou J; Liu X; Xie Q; Wang Y
Vaccine; 2011 Jul; 29(33):5459-66. PubMed ID: 21641956
[TBL] [Abstract][Full Text] [Related]
13. Comparison of humoral neutralizing antibody response in rabbits, guinea pigs, and cattle vaccinated with epsilon and beta toxoids from Clostridium perfringens and C. botulinum types C and D toxoids.
Silva ROS; Duarte MC; Oliveira Junior CA; de Assis RA; Lana AMQ; Lobato FCF
Anaerobe; 2018 Dec; 54():19-22. PubMed ID: 30076896
[TBL] [Abstract][Full Text] [Related]
14. Effectiveness of Chitosan Nanoparticles in Development of Pentavalent Clostridial Toxoid Vaccine in Terms of Clinical Pathology Elements and Immunological Responses.
Fathi Najafi M; Rahman Mashhadi M; Hemmaty M
Arch Razi Inst; 2020 Oct; 75(3):385-395. PubMed ID: 33025779
[TBL] [Abstract][Full Text] [Related]
15. Development of a recombinant toxin fragment vaccine for Clostridium difficile infection.
Karczewski J; Zorman J; Wang S; Miezeiewski M; Xie J; Soring K; Petrescu I; Rogers I; Thiriot DS; Cook JC; Chamberlin M; Xoconostle RF; Nahas DD; Joyce JG; Bodmer JL; Heinrichs JH; Secore S
Vaccine; 2014 May; 32(24):2812-8. PubMed ID: 24662701
[TBL] [Abstract][Full Text] [Related]
16. Enterotoxigenic Escherichia coli Adhesin-Toxoid Multiepitope Fusion Antigen CFA/I/II/IV-3xSTa
Nandre R; Ruan X; Lu T; Duan Q; Sack D; Zhang W
Infect Immun; 2018 Mar; 86(3):. PubMed ID: 29263112
[TBL] [Abstract][Full Text] [Related]
17. Purification and characterization of Clostridium sordellii lethal toxin and cross-reactivity with Clostridium difficile cytotoxin.
Popoff MR
Infect Immun; 1987 Jan; 55(1):35-43. PubMed ID: 3793234
[TBL] [Abstract][Full Text] [Related]
18. Potency testing of Cl. sordellii bacterin-toxoids by means of a mouse protection test.
Haas HF
Dev Biol Stand; 1976; 32():167-72. PubMed ID: 1001830
[TBL] [Abstract][Full Text] [Related]
19. Toxoid of Clostridium botulinum type F: purification and immunogenicity studies.
Hatheway CL
Appl Environ Microbiol; 1976 Feb; 31(2):234-42. PubMed ID: 793522
[TBL] [Abstract][Full Text] [Related]
20. Cytotoxin CctA, a major virulence factor of Clostridium chauvoei conferring protective immunity against myonecrosis.
Frey J; Johansson A; Bürki S; Vilei EM; Redhead K
Vaccine; 2012 Aug; 30(37):5500-5. PubMed ID: 22749595
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
